Quantifying the risks and benefits of natalizumab in relapsing multiple sclerosis.

Source:http://linkedlifedata.com/resource/pubmed/id/17470756

Neurology 2007 May 1 68 18 1524-8

Download in:

View as

Triples

General Info

PMID
17470756